Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 27,711 | 28,235 | 16,605 | 10,234 | 8,819 |
| Cost of Goods | 10,207 | 9,141 | 5,779 | 3,276 | 3,703 |
| Gross Profit | 17,504 | 19,094 | 10,826 | 6,958 | 5,116 |
| Operating Expenses | 37,794 | 40,104 | 25,881 | 21,119 | 17,211 |
| Operating Income | -20,083 | -20,869 | -14,276 | -13,885 | -11,392 |
| Interest Expense | 46 | 8 | 104 | 136 | 158 |
| Other Income | 720 | 1,041 | -311 | 183 | 64 |
| Pre-tax Income | -19,409 | -19,836 | -14,691 | -13,838 | -11,486 |
| Income Tax | -7,503 | -130 | -3,907 | -156 | 64 |
| Net Income Continuous | -11,906 | -19,706 | -10,784 | -13,682 | -11,550 |
| Net Income Discontinuous | N/A | N/A | 73,503 | 8,620 | 7,600 |
| Minority Interests | -10 | N/A | N/A | N/A | N/A |
| Net Income | $-11,896 | $-19,706 | $62,719 | $-5,062 | $-3,950 |
| EPS Basic Total Ops | -0.35 | -0.58 | 1.89 | -0.16 | -0.15 |
| EPS Basic Continuous Ops | -0.35 | -0.58 | -0.32 | -0.44 | -0.42 |
| EPS Basic Discontinuous Ops | N/A | N/A | 2.21 | 0.27 | 0.28 |
| EPS Diluted Total Ops | -0.35 | -0.58 | 1.83 | -0.17 | -0.15 |
| EPS Diluted Continuous Ops | -0.35 | -0.58 | -0.32 | -0.44 | -0.42 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 2.14 | 0.27 | 0.28 |
| EPS Diluted Before Non-Recurring Items | -0.57 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,196 | $-20,115 | $-13,607 | $-13,189 | $-10,658 |